AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.
发明人:
申请号：
IL21671711
公开号：
IL216717A
申请日:
2011.12.01
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
Use of benzydamine in the treatment of inflammatory diseases, in particular Crohn's disease, rheumatoid arthritis, psoriatic arthritis, and psoriasis, caused by an expression or overexpression of the cytokine subunit p40.
